Drug Type CAR-T |
Synonyms AntiCA199/CEA CAR T cell therapy SMT Bio/Yonsei Medical Center, AntiCEA/CA199 CAR T cell therapy SMT Bio/Yonsei Medical Center, AntiCEA/CA199 chimeric antigen receptor T cell therapy |
Target |
Mechanism CEA inhibitors(Carcinoembryonic antigen inhibitors), Gene transference, T lymphocyte replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Biliary Tract Neoplasms | Preclinical | KR | - | |
Biliary Tract Neoplasms | Preclinical | KR | - | |
Pancreatic Carcinoma | Preclinical | KR | - | |
Pancreatic Carcinoma | Preclinical | KR | - |